Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Adherium Ltd. ( (AU:ADR) ) has issued an announcement.
Adherium Ltd. announced the quotation of 4,000,000 fully paid ordinary shares on the Australian Securities Exchange (ASX), effective December 5, 2025. This issuance is part of previously announced transactions, potentially enhancing the company’s market presence and providing additional capital for its operations, which may positively impact its stakeholders and industry positioning.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Ltd. operates in the healthcare industry, focusing on developing and providing digital health technologies. The company specializes in creating smart inhaler devices that aim to improve medication adherence and patient outcomes, primarily targeting respiratory conditions such as asthma and COPD.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.97M
Learn more about ADR stock on TipRanks’ Stock Analysis page.